2023-07-31 13:07:06 ET
- Esperion Therapeutics ( NASDAQ: ESPR ) is scheduled to announce Q2 earnings results on Tuesday, August 1st, before market open.
- The consensus EPS Estimate is -$0.63 (+40.0% Y/Y) and the consensus Revenue Estimate is $24.64M (+30.8% Y/Y).
- Over the last 2 years, ESPR has beaten EPS estimates 75% of the time and has beaten revenue estimates 63% of the time.
- Over the last 3 months, EPS estimates have seen 3 upward revisions and 2 downward. Revenue estimates have seen 2 upward revisions and 2 downward.
For further details see:
Esperion Therapeutics Q2 2023 Earnings Preview